Literature DB >> 15297938

Epidemiology of upper gastrointestinal malignancies.

Katherine D Crew1, Alfred I Neugut.   

Abstract

The demographics of esophageal and gastric cancer have been changing dramatically in the United States over the past several decades. While incidence rates for esophageal squamous cell carcinoma and distal gastric carcinoma have been declining, the trends for adenocarcinoma of the esophagus and proximal stomach have been rising rapidly, particularly among white males. The incidence of these upper gastrointestinal (GI) malignancies varies widely based on geographic location, race, and socioeconomic status. The primary causes of squamous cell carcinoma of the esophagus are tobacco use and alcohol consumption, whereas the main risk factors for adenocarcinoma of the esophagus are gastroesophageal reflux disease and obesity. Dietary factors and Helicobacter pylori infection play an important role in the development of gastric cancer. Understanding the epidemiology and etiologies of esophageal and gastric carcinomas will lead to the development of interventions for screening and prevention in high-risk populations.

Entities:  

Mesh:

Year:  2004        PMID: 15297938     DOI: 10.1053/j.seminoncol.2004.04.021

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  108 in total

1.  New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Renyong Guo; Chunqin Pan; Jianmin Shen; Chibo Liu
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-21       Impact factor: 4.553

2.  SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.

Authors:  Fernando Rivera; Cristina Grávalos; Rocío García-Carbonero
Journal:  Clin Transl Oncol       Date:  2012-07       Impact factor: 3.405

3.  Second gastric cancers among patients with primary sporadic and familial cancers in Sweden.

Authors:  J Ji; K Hemminki
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 4.  Locally advanced and metastatic gastric cancer: current management and new treatment developments.

Authors:  Kathryn Field; Michael Michael; Trevor Leong
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Exposure to both radiation and chemotherapy increases the risk of Barrett's and multilayered epithelium.

Authors:  Helen M Shields; Abram Recht; Helen H Wang
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

6.  A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.

Authors:  Zhao-Hui Li; Xin-Min Pan; Bao-Wei Han; Xiao-Min Guo; Zhen Zhang; Jing Jia; Lin-Bo Gao
Journal:  Tumour Biol       Date:  2013-06-02

Review 7.  New advances in targeted gastric cancer treatment.

Authors:  Daniela Cornelia Lazăr; Sorina Tăban; Marioara Cornianu; Alexandra Faur; Adrian Goldiş
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 8.  Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.

Authors:  Sundeep A Chandra; Michael W Nolan; David E Malarkey
Journal:  Toxicol Pathol       Date:  2009-12-17       Impact factor: 1.902

9.  Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.

Authors:  Hai-Lin Jin; Hong Zhu; Ting-Sheng Ling; Hong-Jie Zhang; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

10.  Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy.

Authors:  Chuang-Zhen Chen; Jian-Zhou Chen; De-Rui Li; Zhi-Xiong Lin; Ming-Zhen Zhou; Dong-Sheng Li; Zhi-Jian Chen
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.